Kansas Gov. Sam Brownback is expected to veto expansion of Medicaid in Kansas. » Read More
By: Bertha Coombs
The GOP health-care bill's defeat removes uncertainty for insurers as they prep 2018 rates, but unresolved legal issues remain. » Read More
House Republican leaders last week canceled a planned vote on their Obamacare replacement because of opposition by members of the party. » Read More
Almost 200,000 people have fatally overdosed on opioids in the past 15 years, with more than 30,000 people dying in 2015 alone. » Read More
The U.S. surgeon general on Thursday called for action to reduce the use of e-cigarettes among young people.
The American Academy of Actuaries said more insurers could bolt the market, and fewer people could end up being insured.
President-elect Donald Trump made his promise, which echoes past criticisms on drug pricing, in an interview for Time magazine's Person of the Year issue.
By 2019, the number of people without insurance would be nearly 59 million, with an uninsured rate of 21 percent, a new analysis says.
Health-care stocks haven't gotten the green light many expected from Hillary Clinton's election loss.
Ryan and his House GOP colleagues have tried numerous times to repeal the law but were never able to during Obama's tenure.
Researchers have found a functional link between gut bacteria and Parkinson's disease.
Kenneth Frazier, the CEO of pharmaceutical giant Merck, says Trump's call to revamp Obamacare could prove useful.
Scientists are taking a new approach to the riddle of preterm birth, which kills 1 million babies globally each year.
One woman explains how the President-elect's actions on Obamacare could actually threaten her life.
In the likely repeal of the Affordable Care Act, these health-care stocks should perform well, according to some analysts.
Everyone from government to independent foundations are funding microbiome research. Why bacteria's DNA is garnering so much attention.
President-elect Donald Trump will choose Georgia Rep. Tom Price to head the Department of Health and Human Services, a source told NBC News.
Overturning Obamacare without plunging the health system into chaos may be easier said than done.
Health spending on privately insured people rose 4.6 percent, with much of the increase coming from prescription drugs and medical services.
Hospitals that benefited under Obamacare likely will see a reversal of fortune and there are new risks for already struggling insurers.
Juno Therapeutics shares shed 24 percent Wednesday after the biopharmaceutical company announced complications with its Phase II clinical trial of JCAR015.
Solanezumab, an experimental drug from Eli Lilly, failed to slow the loss of cognitive ability in patients with mild Alzheimer's disease.
You might survive going to the emergency room — but the "surprise" bill you get later could be a real killer.
One-third of U.S. adults reported not getting recommended health care and not going to the doctor when sick because of the costs.
Get the best of CNBC in your inbox